HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

G D Demetri Selected Research

Tyrosine Kinase Inhibitors

1/2016Long-term follow-up results of the multicenter phase II trial of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of standard tyrosine kinase inhibitor therapy.
4/2014Genome-wide functional screening identifies CDC37 as a crucial HSP90-cofactor for KIT oncogenic expression in gastrointestinal stromal tumors.
4/2001Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


G D Demetri Research Topics

Disease

14Neoplasms (Cancer)
01/2016 - 04/2000
13Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2016 - 04/2001
10Sarcoma (Soft Tissue Sarcoma)
11/2020 - 10/2000
3Liposarcoma
01/2018 - 03/2012
3Disease Progression
04/2014 - 04/2004
2Leiomyosarcoma
01/2018 - 06/2013
2Hypertension (High Blood Pressure)
01/2016 - 12/2012
2Neoplasm Metastasis (Metastasis)
04/2014 - 09/2008
2Neutropenia
10/2013 - 01/2001
2Thrombocytopenia (Thrombopenia)
01/2001 - 04/2000
1Renal Cell Carcinoma (Grawitz Tumor)
12/2012
1Myxoid Liposarcoma
03/2012
1Ewing Sarcoma (Sarcoma, Ewing)
09/2008
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2001
1Rhabdomyosarcoma
08/2001
1Chronic Kidney Failure (Chronic Renal Failure)
04/2001
1Infections
01/2001
1Anemia
01/2001

Drug/Important Bio-Agent (IBA)

11Imatinib Mesylate (Gleevec)FDA Link
04/2014 - 04/2001
7TrabectedinIBA
01/2018 - 04/2004
5Phosphotransferases (Kinase)IBA
11/2020 - 10/2001
4Sunitinib (Sutent)FDA Link
01/2014 - 09/2008
3Tyrosine Kinase InhibitorsIBA
01/2016 - 04/2001
3Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
09/2008 - 10/2001
3Biological ProductsIBA
09/2008 - 04/2001
3Pharmaceutical PreparationsIBA
09/2008 - 10/2001
2Proteins (Proteins, Gene)FDA Link
09/2007 - 10/2001
2Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
09/2007 - 10/2001
2Oncogene Proteins (Oncogene Protein)IBA
09/2007 - 08/2001
2Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA
10/2001 - 08/2001
2Thrombopoietin (c-mpl Ligand)IBA
01/2001 - 04/2000
1tyrosine receptor (receptor, tyrosine)IBA
11/2020
1TropomyosinIBA
11/2020
1Dacarbazine (DIC)FDA LinkGeneric
01/2018
1AnthracyclinesIBA
01/2018
1regorafenibIBA
01/2016
1pazopanibFDA Link
01/2014
1Alanine Transaminase (SGPT)IBA
10/2013
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
10/2013
1Biomarkers (Surrogate Marker)IBA
12/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2012
1nilotinibFDA Link
07/2012
1EverolimusFDA Link
10/2010
1Protein Kinase C-thetaIBA
09/2008
1Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
11/2007
1Tyrosine (L-Tyrosine)FDA Link
09/2007
1AlkaloidsIBA
04/2004
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2001
1ErythropoietinFDA Link
04/2001
1LigandsIBA
01/2001
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2001
1Interleukin-11 (Interleukin 11)IBA
04/2000
1CytokinesIBA
04/2000
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2000

Therapy/Procedure

13Therapeutics
11/2020 - 01/2001
12Drug Therapy (Chemotherapy)
01/2018 - 04/2000
2Radiotherapy
11/2001 - 10/2001
1Drug Tapering
01/2016
1Salvage Therapy
02/2013
1Adjuvant Chemotherapy
11/2004
1Platelet Transfusion (Blood Platelet Transfusions)
01/2001